Global Neurovascular Devices & Interventional Neurology Market Growth (Status and Outlook) 2025-2031

The global Neurovascular Devices & Interventional Neurology market size is predicted to grow from US$ 3522 million in 2025 to US$ 4770 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.

Neurovascular devices refer to a range of medical devices used for the diagnosis, treatment, and management of diseases related to the nervous system, particularly those involving the brain, spinal cord, and their blood vessels. These devices play a vital role in the diagnosis and treatment of conditions such as stroke, cerebral aneurysms, cerebrovascular diseases, traumatic brain injuries, and other neurovascular disorders. Neurovascular devices include thrombectomy devices, intracranial stents, embolization devices, and flow diversion devices, which are widely used in neurointerventional procedures. Interventional neurology refers to a medical specialty that utilizes minimally invasive techniques to treat neurological diseases, such as catheter-based approaches, percutaneous punctures, or endovascular interventions. These procedures directly target the neurological system and blood vessels, repairing or modifying damaged areas. In particular, interventional neurology has achieved significant success in the treatment of stroke, aneurysms, and cerebrovascular stenosis, offering a less invasive alternative to traditional surgery, resulting in shorter recovery times and reduced treatment risks.

Market Development Opportunities and Key Drivers: The growth of the neurovascular devices and interventional neurology market is driven by several key factors:

1. Aging Population: As the global population ages, the incidence of stroke, aneurysms, and other age-related neurovascular diseases continues to rise. This leads to an increased demand for related treatment devices.

2. Technological Advancements: Continuous advancements in medical imaging and minimally invasive surgery techniques have significantly improved the success and safety rates of neurointerventional procedures, driving the adoption of neurovascular devices.

3. Widespread Early Diagnosis and Treatment: With improvements in diagnostic tools and growing awareness of cerebrovascular diseases, more patients are receiving treatment at earlier stages, thereby increasing the demand for neurovascular devices.

4. Patient Preference for Minimally Invasive Treatment: Compared to traditional open surgeries, minimally invasive procedures are preferred by patients due to smaller incisions, quicker recovery times, and reduced risks, which has led to a rise in neurointerventional treatments.

Market Risks:

1. High Treatment Costs: Neurovascular devices and interventional neurology equipment are often expensive, which may limit their adoption in certain countries and regions.

2. Technology Dependence: These devices rely heavily on advanced technologies, such as medical imaging and catheter-based techniques, which can increase the technical demands on healthcare professionals and the risk of complications.

3. Regulatory and Certification Issues: Different regions have varying regulatory standards and approval processes for medical devices, which may present challenges in terms of market entry and device promotion.

Market Concentration: The global neurovascular device market is dominated by several large companies, including Medtronic, Abbott, and Stryker. These companies possess strong competitive advantages in terms of technology development, market penetration, and product supply chains. However, many small and medium-sized enterprises are emerging in the market, driving innovation and product diversification.

Downstream Demand Trends:

1. Increasing Demand for Stroke Treatment: As the incidence of stroke rises globally, there is a growing demand for thrombectomy devices and stents.

2. Rising Demand for Aneurysm and Stenosis Treatment: The treatment of cerebral aneurysms and vascular stenosis is increasing, leading to a greater need for embolization devices and stents.

3. Widespread Adoption of Minimally Invasive Surgeries: The preference for minimally invasive procedures is boosting the adoption of neurointerventional treatments, further driving the demand for neurovascular devices.

Latest Technologies:

1. Thrombectomy Technology: Thrombectomy devices enable rapid and effective treatment for acute ischemic stroke patients, significantly improving survival rates.

2. Flow Diversion Devices: Used for treating cerebral aneurysms, these devices alter the blood flow path, reducing the risk of aneurysm rupture.

3. 3D Imaging Technology: Coupled with 3D imaging, doctors can precisely locate the site of the lesion, improving the success rate of surgeries.

These technological innovations and market trends continue to shape the neurovascular devices and interventional neurology market, making it one of the most promising sectors in the medical device industry.

LPI (LP Information)' newest research report, the “Neurovascular Devices & Interventional Neurology Industry Forecast” looks at past sales and reviews total world Neurovascular Devices & Interventional Neurology sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurovascular Devices & Interventional Neurology sales for 2025 through 2031. With Neurovascular Devices & Interventional Neurology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Devices & Interventional Neurology industry.

This Insight Report provides a comprehensive analysis of the global Neurovascular Devices & Interventional Neurology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurovascular Devices & Interventional Neurology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Devices & Interventional Neurology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Devices & Interventional Neurology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Devices & Interventional Neurology.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Devices & Interventional Neurology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Thrombectomy Devices
Intracranial Stents
Embolization Devices
Flow Diversion Devices
Others

Segmentation by Application:
Hospitals
Clinics
Ambulatory Surgical Units

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo Neuro
Penumbra, Inc. (Neuro)
Shanghai MicroPort Medical (Group) Co.，Ltd.
Abbott Vascular
Medical Murray
Boston Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.